Due to its smaller size, tumor penetration was enhanced with 64Cu–DOTA–HAC–PD-1, showing binding to PD-L1 on tumor cells that appeared to be inaccessible to larger antibody binding (77). This evidence concerns the gene CD274 and neoplasm.